Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
CBFB | hg38_v1_chr16_+_67029133_67029185 | 0.04 | 8.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_46798998 Show fit | 2.62 |
ENST00000640628.1
ENST00000271153.8 ENST00000371923.9 ENST00000371919.8 ENST00000614163.4 |
cytochrome P450 family 4 subfamily B member 1 |
|
chr6_-_75202792 Show fit | 2.37 |
ENST00000416123.6
|
collagen type XII alpha 1 chain |
|
chr3_-_99850976 Show fit | 2.32 |
ENST00000487087.5
|
filamin A interacting protein 1 like |
|
chr22_+_22880706 Show fit | 2.01 |
ENST00000390319.2
|
immunoglobulin lambda variable 3-1 |
|
chr15_+_49423233 Show fit | 1.57 |
ENST00000560270.1
ENST00000267843.9 ENST00000560979.1 |
fibroblast growth factor 7 |
|
chr22_+_31082860 Show fit | 1.46 |
ENST00000619644.4
|
smoothelin |
|
chr10_+_17228515 Show fit | 1.35 |
ENST00000478746.1
|
vimentin |
|
chr20_+_46008900 Show fit | 1.26 |
ENST00000372330.3
|
matrix metallopeptidase 9 |
|
chr14_-_24508251 Show fit | 1.11 |
ENST00000250378.7
ENST00000206446.4 |
chymase 1 |
|
chr4_+_70226116 Show fit | 1.04 |
ENST00000317987.6
|
follicular dendritic cell secreted protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.7 | 2.6 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 2.4 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 2.0 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.0 | 1.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.5 | 1.6 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
0.1 | 1.3 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.4 | 1.1 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.1 | 1.0 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.0 | 1.0 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.4 | GO:0005882 | intermediate filament(GO:0005882) |
0.5 | 2.4 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.0 | 2.2 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 1.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 1.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 0.7 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 0.4 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.0 | 0.4 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 4.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.4 | 3.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 2.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 2.4 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 2.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 1.8 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 1.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 1.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 1.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.9 | GO:0001849 | complement component C1q binding(GO:0001849) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 3.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 1.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 0.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 2.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 2.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 2.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.6 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |